1037. Qualitative Findings from a Hybrid III Implementation-Effectiveness Study to Explore Perspectives of Health-care Staff on Early Implementation of Cabotegravir and Rilpivirine Long Acting (CAB+RPV LA) Injectable HIV treatment in the US (CUSTOMIZE)

BACKGROUND: CAB+RPV LA administered monthly for HIV treatment is non-inferior to daily oral ART at maintaining HIV suppression but concerns about implementation of this novel treatment paradigm remain. CUSTOMIZE, an implementation-effectiveness study, examined barriers and facilitators to successful...

Descripción completa

Detalles Bibliográficos
Autores principales: Czarnogorski, Maggie, Garris, Cindy, Wannamaker, Paul, D’Amico, Ronald, Selenski, Carolyn, Williams, Will, McHorney, Colleen A, Stassek, Larissa, Wohlfeiler, Michael, Sinclair, Gary I, Mena, Leandro A, Margolis, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777284/
http://dx.doi.org/10.1093/ofid/ofaa439.1223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777284/
http://dx.doi.org/10.1093/ofid/ofaa439.1223

Ejemplares similares